Liver fluke control in cattle: why, when and how?

被引:0
|
作者
Forbes, A. [1 ]
机构
[1] Green End Farm, Ware SG11 2PG, Herts, England
关键词
Liver fluke; fasciolosis; pathology; epidemiology; control; FASCIOLA-HEPATICA; TRICLABENDAZOLE; NITROXYNIL; CLORSULON; SHEEP;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The liver fluke is a common helminth parasite of cattle and sheep and can also infect a variety of other domestic animals and wildlife species such as hares and rabbits; it is also zoonotic. The impact of infection and the expression of disease differs somewhat between cattle and sheep and this has implications in terms of control in both species. The consequences of fasciolosis in cattle can be considered under three broad headings: anaemia directly caused by adult parasites feeding on blood; liver damage with manifestations including metabolic and endocrine dysfunction; and immunomodulation that can alter the host responses to other pathogens, notably bovine tuberculosis. The life cycle and epidemiology of Fasciola hepatica are well understood, but practical control options other than anthelmintics, are generally limited by topographical and management constraints. There is a relatively small choice of flukicidal products and several have meat or milk withdrawal times that render them difficult and/or uneconomic to incorporate into routine farm health management practices. This paper reviews and summarises some of the key aspects of the pathology, impact and epidemiology of liver fluke in cattle in order to provide veterinary clinicians with a rational basis for control so that they can tailor their advice appropriately.
引用
收藏
页码:150 / 156
页数:7
相关论文
共 50 条
  • [31] HYPOTHESES - WHY WHEN HOW
    ARMSTRON.RL
    PHI DELTA KAPPAN, 1974, 56 (03) : 213 - 214
  • [32] CABG: When, why, and how?
    Dimeling, George
    Bakaeen, Maurice
    Khatri, Jaikirshan
    Bakaeen, Faisal G.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (05) : 295 - 303
  • [33] LITHIUM - WHEN, HOW, WHY
    PETIT, M
    LEMOINE, JM
    REVUE DU PRATICIEN, 1980, 30 (56): : 3953 - 3957
  • [34] Neuroprotection: Why, when and how
    Quintana, Francisco
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [35] Revolution - Why, How, When?
    Edwards, Lyford P.
    ANNALS OF THE AMERICAN ACADEMY OF POLITICAL AND SOCIAL SCIENCE, 1940, 211 : 207 - 207
  • [36] MRI: When? How? Why?
    Le Bas, JF
    Grand, S
    Pasquier, B
    Kahane, P
    Durand, C
    Minotti, L
    Munari, C
    Benabid, AL
    EPILEPSIES PARTIELLES GRAVES PHARMACO-RESISTANTES DE L'ENFANT: STRATEGIES DIAGNOSTIQUES ET TRAITEMENTS CHIRURGICAUX, 1998, : 152 - 165
  • [37] TAVR - HOW, WHEN AND WHY?
    Hafizullah, Mohammad
    Aman, Wahaj
    PAKISTAN HEART JOURNAL, 2018, 51 (04): : 260 - 263
  • [38] Editorials: Why, when, and how
    DeMaria, AN
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) : 709 - 710
  • [39] Not if but when; no longer why but how
    Ian Piper
    Critical Care, 11
  • [40] STABILIZATION: WHY? HOW? WHEN?
    Kiddy, Arthur W.
    FOREIGN AFFAIRS, 1935, 13 (03) : 398 - 408